Paper40575111
IBS May Have a Causal Effect on Increased Tryptophan Metabolites Levels: Insights from a Bidirectional Two-Sample Mendelian Randomization Study.
Cheng P and 5 others. Int J Tryptophan Res, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. IBS May Have a Causal Effect on Increased Tryptophan Metabolites Levels: Insights from a Bidirectional Two-Sample Mendelian Randomization Study. Papers, record 40575111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40575111
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- IBS May Have a Causal Effect on Increased Tryptophan Metabolites Levels: Insights from a Bidirectional Two-Sample Mendelian Randomization Study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24816252 | An atlas of genetic influences on human blood metabolites. | Nat Genet | 2014 | https://conductscience.org/library/papers/24816252 | PubMed |
| 2 | 32001714 | Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis. | Nat Commun | 2020 | https://conductscience.org/library/papers/32001714 | PubMed |
| 3 | 36539012 | A multi-omic brain gut microbiome signature differs between IBS subjects with different bowel habits. | Neuropharmacology | 2023 | https://conductscience.org/library/papers/36539012 | PubMed |
| 4 | 36732586 | The neurobiology of irritable bowel syndrome. | Mol Psychiatry | 2023 | https://conductscience.org/library/papers/36732586 | PubMed |
| 5 | 31345143 | The Relationship Between the Serotonin Metabolism, Gut-Microbiota and the Gut-Brain Axis. | Curr Drug Metab | 2019 | https://conductscience.org/library/papers/31345143 | PubMed |
| 6 | 17029611 | Acute tryptophan depletion alters gastrointestinal and anxiety symptoms in irritable bowel syndrome. | Am J Gastroenterol | 2006 | https://conductscience.org/library/papers/17029611 | PubMed |
| 7 | 32122523 | Tryptophan in health and disease. | Adv Clin Chem | 2020 | https://conductscience.org/library/papers/32122523 | PubMed |
| 8 | 34463082 | Recent advances in the treatment of irritable bowel syndrome. | Pol Arch Intern Med | 2021 | https://conductscience.org/library/papers/34463082 | PubMed |
| 9 | 34631603 | Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/34631603 | PubMed |
| 10 | 31825083 | Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain. | Adv Nutr | 2020 | https://conductscience.org/library/papers/31825083 | PubMed |
| 11 | 34576297 | Kynurenine Pathway of Tryptophan Metabolism in Migraine and Functional Gastrointestinal Disorders. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34576297 | PubMed |
| 12 | 29902437 | Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. | Cell Host Microbe | 2018 | https://conductscience.org/library/papers/29902437 | PubMed |
| 13 | 30940523 | Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review. | Gastroenterology | 2019 | https://conductscience.org/library/papers/30940523 | PubMed |
| 14 | 28164854 | The Microbiome-Gut-Brain Axis in Health and Disease. | Gastroenterol Clin North Am | 2017 | https://conductscience.org/library/papers/28164854 | PubMed |
| 15 | 19234110 | Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19234110 | PubMed |
| 16 | 33946961 | Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms. | Nutrients | 2021 | https://conductscience.org/library/papers/33946961 | PubMed |
| 17 | 38031265 | A High-Tryptophan Diet Alleviated Cognitive Impairment and Neuroinflammation in APP/PS1 Mice through Activating Aryl Hydrocarbon Receptor via the Regulation of Gut Microbiota. | Mol Nutr Food Res | 2024 | https://conductscience.org/library/papers/38031265 | PubMed |
| 18 | 31473156 | Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. | J Acad Nutr Diet | 2020 | https://conductscience.org/library/papers/31473156 | PubMed |
| 19 | 37111056 | The Usefulness of the Low-FODMAP Diet with Limited Tryptophan Intake in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome. | Nutrients | 2023 | https://conductscience.org/library/papers/37111056 | PubMed |
| 20 | 33407171 | Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis. | BMC Gastroenterol | 2021 | https://conductscience.org/library/papers/33407171 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41280921 | Gut microbiota in irritable bowel syndrome: a narrative review of mechanisms and microbiome-based therapies. | Front Immunol | 2025 | https://conductscience.org/library/papers/41280921 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40575111
GET https://conductscience.org/api/papers/v1/40575111/references?page=2